• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Onduo

7 innovative digital health offerings to treat diabetes

September 28, 2022 By Sean Whooley

MIT Insulin Dosing device diabetes

From using your smartphone to track data to reversing your diabetes altogether, these digital health technologies stand out. Advances in treatments for diabetes never stop coming. Whether that be in the form of insulin pumps or continuous glucose monitors, we’ve seen plenty. Moving away from the physical device, innovations in the digital diabetes space continue […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Better Therapeutics, dariohealth, Dexcom, Diabetes, Glytec, Onduo, One Drop, Sword Health, Verily, Virta Health, Zillion

Verily’s Onduo, Sword Health collaborate on virtual diabetes care

August 17, 2022 By Sean Whooley

Logos of Verily Onduo and Sword Health

Onduo announced today that it entered into a strategic collaboration with Sword Health to broaden virtual care for diabetes and other conditions. Sword Health, a digital musculoskeletal (MSK) care provider, will work with Onduo by Verily, an Alphabet sister company of Google. The idea is to offer complementary solutions, broadening access to virtual care benefits […]

Filed Under: Business/Financial News, Diabetes, Featured, Technology Tagged With: Google, Onduo, Sword Health, Verily

Onduo taps Glytec’s insulin therapy software as part of virtual diabetes clinic

November 29, 2017 By Sarah Faulkner

Glytec

Glytec has inked a deal with Onduo to integrate the company’s Glucommander Outpatient insulin management software into Onduo’s virtual diabetes clinic. Onduo, a joint venture of Sanofi (NYSE:SNY) and Verily, is reportedly working to develop a platform that brings together medical devices, software and support from healthcare experts to help people manage their Type II diabetes. The […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Glytec, Onduo, Sanofi-Aventis, Verily

Sanofi, Google’s Verily launch $500m Onduo diabetes JV

September 12, 2016 By Brad Perriello

Sanofi, Verily form Onduo

Sanofi (NYSE:SNY) and Verily Life Sciences, the healthcare play owned by Google parent Alphabet (NSDQ:GOOGL), are launching a joint venture to tackle diabetes. The Cambridge, Mass.-based Onduo JV will aim to combine Verily’s expertise in miniaturized electronics, analytics, and consumer software with Sanofi’s diabetes program. Dr. Joshua Riff, formerly senior vice president of prevention & wellbeing at UnitedHealth‘s (NYSE:UNH) Optum business, was tapped to be […]

Filed Under: Diabetes, Drug-Device Combinations, Wall Street Beat Tagged With: Onduo, Sanofi-Aventis, Verily

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS